Paper
The complex mechanism of antimycobacterial action of 5-fluorouracil.
Published Jan 22, 2015 · Vinayak Singh, M. Brecik, R. Mukherjee
Chemistry & biology
UNKNOWN SJR score
86
Citations
6
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
In Vitro Study
Highly CitedStudy Snapshot
5-fluorouracil's antimycobacterial action involves upp-catalyzed conversion to FUMP, pyrR resistance, and inhibition of ThyX by fluorodeoxyuridylate.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...
References
Synthesis and evaluation of 5-substituted-2'-deoxyuridine monophosphate analogues as inhibitors of flavin-dependent thymidylate synthase in Mycobacterium tuberculosis
5-Substituted-2'-deoxyuridine monophosphate analogues show potential as inhibitors of flavin-dependent thymidylate synthase in Mycobacterium tuberculosis, offering potential as antibacterial agents.
2015·15citations·Martin Kögler et al.·Collection of Czechoslovak Chemical Communications
Collection of Czechoslovak Chemical Communications
Nucleotide Metabolism and DNA Replication
Advances in mycobacterial genetics and omics techniques have led to a better understanding of nucleotide metabolism and DNA replication, potentially aiding in tuberculosis drug discovery.
2014·27citations·D. Warner et al.·Microbiology Spectrum
Microbiology Spectrum
New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects.
Recent advances in antituberculosis drug discovery and development show promise for improving treatment outcomes, but community involvement is crucial for successful implementation and uptake.
2014·320citations·Alimuddin Zumla et al.·The Lancet. Infectious diseases
The Lancet. Infectious diseases
Assessing the essentiality of the decaprenyl‐phospho‐d‐arabinofuranose pathway in Mycobacterium tuberculosis using conditional mutants
All but one enzyme in the DPA pathway in Mycobacterium tuberculosis are vulnerable to drug attack, with prsA being a particularly attractive new target for drug discovery.
2014·77citations·Gaëlle S. Kolly et al.·Molecular Microbiology
Molecular Microbiology
Tuberculosis drug discovery in the post-post-genomic era
Post-post-genomics technologies, such as whole genome resequencing, have led to new tuberculosis drug candidates, but more advanced technologies are needed to widen therapeutic options.
2014·166citations·Benoit Lechartier et al.·EMBO Molecular Medicine
EMBO Molecular Medicine
Citations
Functional utility of gold complexes with phosphorus donor ligands in biological systems.
Gold complexes with phosphorus donor ligands have diverse biological applications, including catalysts, chemotherapeutic agents, and chemical probes, with potential for new synthetic and repurposing strategies.
2025·1citation·Adedamola S Arojojoye et al.·Coordination chemistry reviews
Coordination chemistry reviews
Deciphering the Antibacterial Mechanisms of 5-Fluorouracil in Escherichia coli through Biochemical and Transcriptomic Analyses
5-fluorouracil (5-FU) effectively kills Escherichia coli through multiple pathways, making it a potential therapeutic candidate against carbapenem-resistant bacterial infections.
2024·3citations·Muchen Zhang et al.·Antibiotics
Antibiotics
Tackling Antibiotic Resistance: Exploring 5-Fluorouracil as a Promising Antimicrobial Strategy for the Treatment of Streptococcus suis Infection
5-fluorouracil (5-FU) shows potential as a promising alternative to antibiotics for treating Streptococcus suis infections, with its ability to target bacterial membrane damage and DNA damage.
2024·4citations·Jing Zuo et al.·Animals : an Open Access Journal from MDPI
Animals : an Open Access Journal from MDPI
Quercetin nanoparticle ameliorates 5-fluorouracil-induced testicular damage in mice: A biochemical and histological study
Quercetin nanoparticles can reduce testicular damage caused by 5-fluorouracil in mice, potentially benefiting cancer patients.
2024·1citation·Soheila Safarpour et al.·South African Journal of Botany
South African Journal of Botany
Improvement of the Genome Editing Tools Based on 5FC/5FU Counter Selection in Clostridium acetobutylicum
The improved pCat-upp/5FU system effectively replaces the ldh gene in Clostridium acetobutylicum, reducing mutagenic effects and enabling efficient genome editing.
2023·2citations·Eglantine Boudignon et al.·Microorganisms
Microorganisms
Preliminary evaluation of zeolite-based platforms as potential dual drug delivery systems against microbial infections in the tumor microenvironment
Zeolite-based delivery systems containing silver and 5-Fluorouracil show potential as effective dual drug delivery systems against microbial infections in tumor microenvironments.
2023·3citations·A. R. Bertao et al.·Microporous and Mesoporous Materials
Microporous and Mesoporous Materials
Anticancer Drug-Loaded Chitosan Nanoparticles for In Vitro Release, Promoting Antibacterial and Anticancer Activities
Chitosan nanoparticles encapsulating cisplatin and 5-fluorouracil show controlled and sustained release, promoting antibacterial and anticancer activities.
2023·8citations·Naushad Ahmad et al.·Polymers
Polymers
Suppressive myeloid cells in SARS-CoV-2 and Mycobacterium tuberculosis co-infection
Myeloid-deprived suppressor cells (MDSC) play a crucial role in the adverse clinical outcomes of TB-COVID-19 coinfection, affecting innate immune sensing and TB control.
2023·2citations·J. Shaw et al.·Frontiers in Immunology
Frontiers in Immunology